EyeCare Partners Showcases Latest Eye Care Innovations at ASCRS 2025 in Los Angeles
EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, is set to make a powerful impact at the 2025 annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS), one of the industry’s most influential conferences. The event, taking place from Friday, April 25, through Monday, April 28, at the Los Angeles Convention Center, will feature ECP’s significant contributions in clinical research, innovative technologies, and expert education. Attendees can visit ECP at Booth #1047 to learn more about its comprehensive approach to advancing eye care.
Demonstrating its commitment to delivering visionary patient outcomes, more than a dozen ECP-affiliated ophthalmologists and optometrists from across the United States will participate in a broad range of activities at ASCRS. These include instructional courses, research presentations, and symposium contributions that highlight the latest scientific advances and clinical practices. ECP’s involvement aims to drive new insights and foster transformative conversations about the future of eye care for millions of patients undergoing cataract and refractive surgeries each year.
“Our participation at ASCRS 2025 reflects the spirit of innovation and collaboration that defines EyeCare Partners,” said Daniel Miller, M.D., Ph.D., Ophthalmology Division President and Executive Medical Officer at ECP. “The findings and clinical insights shared by our team underscore our commitment to ensuring that patients experience the highest standards of care and achieve the best possible vision outcomes for life. It is exciting to see our experts shaping the future of eye care through pioneering research and next-generation technologies.”
This year’s ECP presentations will cover a wide array of groundbreaking topics, from the application of digital surgical tools to the development of artificial iris implants and the use of telehealth follow-ups for cataract surgery patients. These topics reflect the broader trends reshaping the ophthalmology field—where technology, patient-centered innovation, and improved surgical techniques are converging to redefine standards of care.
One of the standout moments at ASCRS 2025 will be the inaugural Holland Lecture during ASCRS Cornea Day, delivered by Dr. Edward Holland, a luminary in the field of cornea services. Dr. Holland, who serves as the Director of Cornea Services at Cincinnati Eye Institute and a Professor of Ophthalmology at the University of Cincinnati, is also the founder of the Holland Foundation for Sight Restoration. His contributions to corneal research and patient care have had a profound impact on countless lives, and ECP is honored to celebrate his achievements at this year’s event.
Key Research and Presentations by ECP Experts at ASCRS 2025:
- Safety, Efficacy, and Surgical Time of a Novel Surgical Headset vs. Standard Ophthalmic Visualization Systems
Presented by Rob Weinstock, M.D., The Eye Institute of West Florida
Dr. Weinstock’s study explores the benefits of a novel surgical visualization headset designed to enhance surgeon ergonomics, improve surgical efficiency, and deliver superior clinical outcomes compared to traditional systems. - The Effectiveness and Safety of Postoperative Day One Telehealth Visits for Uncomplicated Cataract Surgeries
Presented by Albert Cheung, M.D., and Walter Whitley, O.D., MBA, F.A.A.O., Virginia Eye Consultants
This research investigates how telehealth appointments conducted one day after cataract surgery can provide safe, effective postoperative care, offering greater convenience and access for patients without compromising outcomes. - Efficacy of Artificial Iris Prosthesis in the Management of Diffuse Iris Atrophy Due to Herpes Zoster Virus
Presented by Michael Snyder, M.D., and Adam Kaufman, M.D., F.A.C.S, Cincinnati Eye Institute
This presentation focuses on artificial iris implants as a solution for patients suffering from iris atrophy caused by herpes zoster virus, aiming to restore both functionality and appearance. - Spectacle Freedom and Visual Clarity: A Comparative Study of Next-Generation Intraocular Lenses
Presented by Rob Weinstock, M.D., and Neel Desai, M.D., The Eye Institute of West Florida
Drs. Weinstock and Desai evaluate the performance of new-generation intraocular lenses (IOLs) in delivering improved visual clarity and reducing the dependence on corrective eyewear after surgery. - IC-102 The Wonderful World of Iris Prostheses: A Case-Based Compendium
Presented by Michael Snyder, M.D., Cincinnati Eye Institute
This instructional course dives into complex cases involving iris prostheses, offering participants valuable strategies and clinical pearls for managing a variety of challenging scenarios. - IC-123 Premium IOLs in Imperfect Eyes 2025
Presented by Kavitha Sivaraman, M.D., and Michael Snyder, M.D., Cincinnati Eye Institute
This course addresses the challenges and best practices for implanting premium intraocular lenses in eyes that may not meet ideal criteria due to previous surgeries, trauma, or underlying disease. - What I Am Excited About in Presbyopic IOLs
Presented by Elizabeth Yeu, M.D., Virginia Eye Consultants
Dr. Yeu shares her perspectives on emerging innovations in presbyopia-correcting IOL technologies and how they can further improve quality of life for aging patients. - SYM-8 Digital Visualization in Eye Surgery—Is It Time to Adopt?
Moderated by Rob Weinstock, M.D., The Eye Institute of West Florida
A symposium exploring the shift from analog microscopes to digital visualization systems, weighing the advantages, challenges, and transformative potential of this technological evolution. - Mirror, Mirror: Potential Surgical Misadventures from Digital Imaging
Presented by Michael Snyder, M.D., and Christopher Riemann, M.D., Cincinnati Eye Institute
This presentation discusses the potential pitfalls and cautionary tales surrounding the use of digital imaging in surgery, highlighting the importance of proper training and vigilance.
Reflecting on the organization’s impact, Antonio Capone Jr., M.D., Chief Clinical Officer at EyeCare Partners, added, “We are thrilled to be part of ASCRS 2025, a pivotal event that fosters the exchange of ideas and best practices in cataract and refractive surgery. Our research initiatives span a wide range of subspecialties—from innovations in cataract surgery to cutting-edge developments in corneal disease management. With over 500 completed clinical studies across our network, ECP remains deeply committed to driving progress and improving the quality of care for patients worldwide.”
For attendees interested in further details, a comprehensive schedule of all ASCRS 2025 sessions, including EyeCare Partners’ highlighted presentations, can be found on the official ASCRS website. More specific information about the ECP provider sessions is also available through ECP’s online platforms.
With a robust presence at ASCRS 2025 and a reputation for excellence, EyeCare Partners continues to set the pace for the future of ophthalmology—delivering innovation, leadership, and outstanding patient-centered care to communities across the country.
